Patent Grant
9987297
1. Technical Field
The present disclosure relates to polymeric fibers having tissue reactive members and methods of bonding such polymeric fibers to biological tissues.
2. Related Art
Techniques for repairing damaged or diseased tissue are widespread in medicine. Wound closure devices such as sutures, staples and other repair devices such as mesh or patch reinforcements are frequently used for repair. For example, in the case of hernias, techniques involving the use of a mesh or patch to reinforce the abdominal wall are being used. The mesh or patch can generally be held in place by suturing or stapling to the surrounding tissue. Unfortunately, the use of such sutures or staples may increase the patient's discomfort and, in certain instances, there may be a risk of weakening thin or delicate tissue when the sutures or staples are knotted or deformed.
Click chemistry is a popular term for reliable reactions that make it possible for certain chemical building blocks to “click” together and form an irreversible linkage. See, e.g., U.S. Pub. No. 2005/0222427. Since its recent introduction, click chemistry has been used for ligation in biological and medical technology. In the case of azide-alkyne click chemistry, the reactions may be catalyzed or uncatalyzed. For example, copper-free click chemistry was recently developed by Bertozzi and colleagues using difluorinated cyclooctyne or DIFO, that reacts with azides rapidly at physiological temperatures without the need for a toxic catalyst. See, e.g., Baskin et al., Copper Free Click Chemistry for Dynamic In Vivo Imaging, PNAS, vol. 104, no. 43, 16793-16797 (Oct. 23, 2007). The critical reagent, a substituted cyclooctyne, possesses ring strain and electron-withdrawing fluorine substituents that together promote a [3+2] dipolar cycloaddition with azides. See also, U.S. Pub. No. 2006/0110782 and Codelli et al., Second Generation Difluorinated Cyclooctynes for Copper-Free Click Chemistry, J. Am. Chem. Soc., vol. 130, no. 34, 11486-11493 (2008). Another suitable cyclooctyne is 6,7-dimethoxyazacyclooct-4-yne (DIMAC). See, Sletton and Bertozzi, A hydrophilic azacyclooctyne for Cu-free click chemistry, Org. Lett. (2008) 10 (14), 3097-3099. Other click chemistry reactions include Diels-Alder reactions, thiol-alkene reactions, and maleimide-thiol reactions. There is a continuing need to generate improvements in tissue repair technology and advance the state of the art.
The present disclosure describes a polymeric fiber including a surface having a plurality of surface reactive members of a specific binding pair, and a plurality of linking members, each linking member including at least one complimentary surface reactive member of the specific binding pair, and at least one tissue reactive member, wherein the surface reactive members and the complementary surface reactive members are covalently bonded, adhering the tissue reactive members to the surface of the fiber.
A method for bonding a polymeric fiber to biological tissue is also provided which includes: providing a polymeric fiber having a plurality of surface reactive members of a specific binding pair attached on a surface of the fiber; attaching a plurality of linking members to the surface of the polymeric fiber, each linking member having at least one complimentary surface reactive member of the specific binding pair to attach the linking member to the surface of the polymeric fiber and at least one tissue reactive member; and, contacting the polymeric fiber with the biological tissue, wherein upon contact of the tissue reactive members on the surface of the polymeric fiber with the biological tissue, covalent bonds are formed between the tissue reactive members and the biological tissue, thus adhering the polymeric fiber to the biological tissue.
A surgical bonding system is provided in which fibers or filaments having pendant tissue reactive members covalently bond to biological tissue to close or seal a wound. The tissue reactive members may be attached to any portion of the fiber surface via a plurality of linking members. Each linking member includes at least one tissue reactive member and at least one complimentary surface reactive member of a specific binding pair. Prior to attachment of the linking member to the fiber, the fiber surface includes at least one surface reactive member of a specific binding pair, to which the complimentary surface reactive member of the linking member may covalently attach to the fiber. Once the linking member is attached to the fiber, a pendant tissue reactive member is positioned on the fiber for interaction with the biological tissue upon implantation.
In embodiments, the surface reactive members and the complimentary surface active members of a specific binding pair bind to one another via click chemistry. Click chemistry refers to a collection of surface reactive members having a high chemical potential energy capable of producing highly selective, high yield reactions. The surface reactive members react to form extremely reliable molecular connections in most solvents, including physiologic fluids, and often do not interfere with other reagents and reactions. Examples of click chemistry reactions include Huisgen cycloaddition, Diels-Alder reactions, thiol-alkene reactions, and maleimide-thiol reactions.
Huisgen cycloaddition is the reaction of a dipolarophile with a 1,3-dipolar compound that leads to 5-membered (hetero)cycles. Examples of dipolarophiles are alkenes and alkynes and molecules that possess related heteroatom functional groups (such as carbonyls and nitriles). 1,3-Dipolar compounds contain one or more heteroatoms and can be described as having at least one mesomeric structure that represents a charged dipole. They include nitril oxides, azides, and diazoalkanes. Metal catalyzed click chemistry is an extremely efficient variant of the Huisgen 1,3-dipolar cycloaddition reaction between alkyl-aryly-sulfonyl azides, C—N triple bonds and C—C triple bonds which is well-suited herein. The results of these reactions are 1,2 oxazoles, 1,2,3 triazoles or tetrazoles. For example, 1,2,3 triazoles are formed by a copper catalyzed Huisgen reaction between alkynes and alkyl/aryl azides. Metal catalyzed Huisgen reactions proceed at ambient temperature, are not sensitive to solvents, i.e., nonpolar, polar, semipolar, and are highly tolerant of functional groups. Non-metal Huisgen reactions (also referred to as strain promoted cycloaddition) involving use of a substituted cyclooctyne, which possesses ring strain and electron-withdrawing substituents such as fluorine, that together promote a [3+2] dipolar cycloaddition with azides are especially well-suited for use herein due to low toxicity as compared to the metal catalyzed reactions. Examples include DIFO and DIMAC. Reaction of the alkynes and azides is very specific and essentially inert against the chemical environment of biological tissues. One reaction scheme may be represented as:
where R and R′ are a polymeric material or a component of a biologic tissue.
The Diels-Alder reaction combines a diene (a molecule with two alternating double bonds) and a dienophile (an alkene) to make rings and bicyclic compounds. Examples include:
The thiol-alkene (thiol-ene) reaction is a hydrothiolation, i.e., addition of RS—H across a C═C bond. The thiol-ene reaction proceeds via a free-radical chain mechanism. Initiation occurs by radical formation upon UV excitation of a photoinitiator or the thiol itself. Thiol-ene systems form ground state charge transfer complexes and therefore photopolymerize even in the absence of initiators in reasonable polymerization times. However, the addition of UV light increases the speed at which the reaction proceeds. The wavelength of the light can be modulated as needed, depending upon the size and nature of the constituents attached to the thiol or alkene. A general thiol-ene coupling reaction mechanism is represented below:
In accordance with the disclosure herein, a polymeric fiber, such as a surgical suture, is provided with a plurality of surface reactive members of a specific binding pair attached on the surface of the fiber. When the surface reactive members of the fiber are contacted with a linking member containing complementary surface reactive members of the specific binding pair, covalent attachment occurs, thus adhering the linking member to the fiber. In embodiments, the surface reactive members may be a dipolarophile or a 1,3 dipolar compound depending on which complement is applied to the linking member or the fiber. For example, if a dipolarphile is located on the fiber, the 1,3 dipolar compound will be located on the linking member. If a dipolarphile is located on the linking member, the 1,3 dipolar compound will be located on the fiber. In embodiments, the Diels-Alder members of a specific binding pair may be either a diene and a dienophile depending on which complement is applied to the linking member or the fiber. For example, if a diene is located on the fiber, the dienophile can be located on the linking member. If a diene is located on the linking member, the dienophile can be located on the fiber. In embodiments, the thiol-ene members of a specific binding pair may be either a thiol and an alkene depending on which complement is applied to the linking member or the fiber. For example, if a thiol is located on the fiber, the alkene can be located on linking member. If a thiol is located on the linking member, the alkene can be located on the fiber.
The polymeric fiber and the linking member may be constructed from any biocompatible absorbable polymer or biocompatible non-absorbable polymer. Examples of suitable polymers include polycarbonates, polyolefins, polymethacrylates, polystyrenes, polyamides, polyurethanes, polyethylene terephthalate, poly (lactic acid), poly (glycolic acid), poly (hydroxbutyrate), dioxanones (e.g., 1,4-dioxanone), δ-valerolactone, 1,dioxepanones (e.g., 1,4-dioxepan-2-one and 1,5-dioxepan-2-one), poly (phosphazine), polyesters, polyethylene glycol, polyethylene oxides, polyacrylamides, cellulose esters, fluoropolymers, vinyl polymers, silk, collagen, alginate, chitin, chitosan, hyaluronic acid, chondroitin sulfate, glycosaminoglycans, polyhydroxyethylmethylacrylate, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylic acid, polyacetate, polycaprolactone, polypropylene, glycerols, poly(amino acids), copoly (ether-esters), polyalkylene oxalates, polyamides, poly (iminocarbonates), polyalkylene oxalates, polyoxaesters, polyorthoesters, polyphosphazenes, polypeptides and copolymers, block copolymers, homoploymers, blends and combinations thereof.
In the present application, the term “bioresorbable” and “bioabsorbable” are used interchangeably and are intended to mean the characteristic according to which an implant and/or a material is resorbed by the biological tissues and the surrounding fluids and disappears in vivo after a given period of time, that may vary, for example, from one day to several months, depending on the chemical nature of the implant and/or of the material. Non bioresorbable material—also called permanent material—is not substantially resorbed by tissues and surrounding fluids, after 2 years and more, keeping in particular most (e.g., >80%) of their mechanical properties after such a time. The term “biocompatible” is intended to mean the characteristic according to which an implant and/or a material is well integrated by the biological tissues and the surrounding fluids without inducing excessive inflammation reaction around the bulk of the material or due to its degradation. The material should avoid also the formation of a fibrous capsule which usually results in the delay of the cellular integration of a porous implant.
Many of the above described examples of polymers do not contain functional groups in their molecules. In embodiments, the surface reactive members and complimentary surface reactive members are attached to the polymeric fiber or linking member by surface modification techniques such as plasma treatment, silane coupling treatment and acid sensitization. Surface activation of the fiber or linking member can be achieved by acid or base hydrolysis, treatment by means of cold plasma, by chemical reactions or electromagnetic radiations.
Hydrolysis can be conducted in the presence of an aqueous solution of a base or an acid to accelerate surface reaction, inasmuch as excessively long processes of activation can induce a reduction in molecular weight and thus in the mechanical properties of the material. Suitable bases for obtaining watery solutions suited to the aim are, for example, strong alkalis, such as LiOH, Ba(OH)2, Mg(OH)2, NaOH, KOH, Na2CO3, Ca(OH)2 and the weak bases, such as for example NH4OH and the amines such as methylamine, ethylamine, diethylamine and dimethylamine. Acids suitable for surface hydrolysis treatments can be chosen, for example, from among HCl, HClO3, HClO4, H2SO3, H2SO4, H3PO3, H3PO4, HI, HIO3, HBr, lactic acid, glycolic acid. Surface activation by means of hydrolysis can be conducted at temperatures preferably comprised between 0 degrees Celsius and the material softening temperature.
Plasma treatment can be carried out both in the presence of a reactive gas, for example air, Ar, O2 with the formation of surface activation of oxygenate type, such as —OH, —CHO, —COOH.
Surface treatment, whether hydrolytic or with plasma, can remain unaltered or can be followed by further chemical modifications to provide the first reactive groups on the bioabsorbable polymeric surface. Thus, for example, the COONa groups generated by a base hydrolysis can be subsequently converted into COOH groups by treatment with strong mineral acids. Further, the surface freeing of alcoholic groups by means of a hydrolysis process can be followed by reaction by means of the addition of a compound provided with functional group or groups able to react with surface alcoholic groups, such as for example by means of the addition of an anhydride such as succinic anhydride, with the conversion of —OH groups into —O—CO—CH2-CH2-COOH groups. Suitable surface activation techniques are disclosed in U.S. Pat. No. 6,107,453, the entire disclosure of which is incorporated herein by this reference.
During manufacture of the polymeric fiber or linking member, pendant functional groups can be incorporated into the polymer backbone by, e.g., copolymerization with functionalized monomer such as lactones, cyclic carbonates and morpholine-2,5-diones. The azido group, N3 is a nucleophilic group that will exchange with other nucleophilic groups, e.g., —OH, —NH2 and halogens (Br, Cl, or I). For example, 1,3-dipolar compounds may be conjugated to aliphatic polyesters, by copolymerizing ε-caprolactone and α-chloro-ε-caprolactone and then substituting an azide group for the Cl atom. Polyesters can incorporate pendant dipolarophiles, e.g., propargyl groups, by copolymerization of ε-caprolactone and α-propargyl-δ-valerolactone. Copolymers of L-lactide containing propargyl groups may, e.g., be prepared by ring opening copolymerization of 5-methyl-5-propargyloxycarbonyl-1,3-dioxanone with L-lactide at a molar ratio of about 90:10 with ZnEt2 as a catalyst. See, Shi et al., Biomaterials, 29 (2008) 1118-1126. Azide functionalized polystyrene is synthesized using atom transfer radical polymerization and subsequent modification with azidotrimethylsilane and tetrabutylammonium fluoride. See, Dirks, et al., Chem. Comm., (2005) 4172-4174. Azides may be incorporated onto methacrylates, e.g., 3 azidopropyl methacrylate which is copolymerized to a block copolymer. Diels-Alder functionalities and thiol-ene functionalities are likewise incorporated into polymers herein.
In embodiments, the polymeric fiber may be a surgical suture. In some embodiments, the fiber may be a monofilament or a multifilament. In embodiments, the polymeric fiber may include at least one barb. In still other embodiments, the polymeric fiber may be used to form fibrous medical devices. Some non-limiting examples of such fibrous medical devices include sutures, staples, clips, patches and meshes.
The medical device may be selected from any conventional implantable fibrous device suitable for use in tissue reinforcement, e.g., hernia repair, or as an anti-adhesion barrier, hemostatic patch, bandages, pledgets, buttreses and the like. Any of the biocompatible polymers listed above may be utilized.
Indeed, the polymeric fibers described herein, as well as any fibrous medical device, may be formed using any techniques known to those skilled in the art, such as knitting, weaving, braiding, tatting, nonwoven techniques, freeze drying, solvent casting, extruding, molding, spinning, and the like. It is envisioned that the fibers may be formed from any permanent biocompatible materials (e.g. polyesters, polypropylene), biodegradable biocompatible materials (e.g. polylactic acid, polyglycolic acid, oxidized cellulose, and chitosan) or with a combination at any proportion of both permanent and biodegradable materials.
The surface of the polymeric fiber or device includes at least one surface reactive member before the linking member is attached to the fiber. The linking member is provided with at least one complimentary surface reactive member to interact with the surface reactive member of the fiber to form a covalent bond between the fiber and the linking member. The linking member also includes a tissue reactive member which remains capable of interacting with the biological tissue when implanted.
In embodiments, a linking member may be a polymeric material made from any of the suitable polymeric materials described herein. Like some polymeric fibers, the linking member may naturally include the complimentary surface reactive members, however in some embodiments, the linking members may require the addition or attachment of the complimentary surface reactive member. Similarly, the linking member may naturally include the tissue reactive members or the linking members may require the addition or attachment of the tissue reactive members.
The tissue reactive members are functional groups or other molecular segments that react with electrophilic or nucleophilic moieties present at the tissue site, e.g., amino and sulfhydryl groups on peptides, proteins, cell surfaces, and extracellular matrix components, to form covalent bonds. Generally, and as will be appreciated by those skilled in the art, the moieties at the tissue site are nucleophilic. Thus, in certain embodiments, the tissue reactive members may be electrophilic.
The term “nucleophilic” refers to a functional member that is electron rich, has an unshared pair of electrons acting as a reactive site, and reacts with a positively charged or electron-deficient site, generally present on another molecule. The term “nucleophile” refers to a compound having a nucleophilic site.
The term “electrophilic” refers to a functional member that is susceptible to nucleophilic attack, i.e., susceptible to reaction with an incoming nucleophilic member. Electrophilic members herein are typically electron-deficient. The term “electrophile” refers to a compound having an electrophilic site. General examples of electrophilic reactive members include (1) alkenyloxycarbonyl groups, i.e., carboxylic acid esters, and “activated” esters; (2) halocarbonyl groups such as acid chloride groups (—CO—Cl); (3) anhydrides (—(CO)—O—(CO)—R, where R is substituted or unsubstituted alkyl, aryl, alkaryl, etc.); (4) acyl groups (ketones) and formyl groups (aldehydes), including α,β-unsaturated ketones and aldehydes (e.g., —CH═CH—CH═O and —CH═CH—C(CH3)═O); (5) halides, particularly chloro substituents; (6) isocyano groups (—N═C═O); (7) isothiocyano groups (—N═C═S); (8) epoxides; (9) activated hydroxyl groups (e.g., activated with conventional activating agents such as carbonyldiimidazole or sulfonyl chloride); and (10) alkenyl groups, including conjugated olefins, such as ethenesulfonyl (—SO2CH═CH2) and analogous functional groups, including acrylate (—CO2—C═CH2), methacrylate (—CO2—C(CH3)═CH2)), ethyl acrylate (—CO2—C(CH2CH3)═CH2), and ethyleneimino (—CH═CH—C═NH).
Further examples of electrophilic tissue reactive members include, without limitation: mixed anhydrides such as PEG-glutaryl-acetyl-anhydride; PEG-glutaryl-isovaleryl-anhydride; PEG-glutaryl-pivalyl-anhydride; ester derivatives of p-nitrophenol, p-nitrothiophenol, and pentafluorophenol; esters of substituted hydroxylamines such as those of N-hydroxy-phthalimide, N-hydroxy-succinimide, and N-hydroxy-glutarimide; esters of 1-hydroxybenzotriazole, 3-hydroxy-3,4-dihydrobenzotriazine-4-one and 3-hydroxy-3,4-dihydro-quinazoline-4-one; derivatives of carbonylimidazole; and isocyanates. With these compounds auxiliary reagents can also be used to facilitate bond formation. For example 1-ethyl-3-(3-dimethylaminopropyl)]carbodiimide can be used to facilitate coupling of carboxyl groups (i.e., glutarate and succinate) with sulfhydryl groups.
It is envisioned that certain tissue reactive members may be more selective to different layers or types of biological tissue. For example, the FGF (fibroblast growth factor) is a ligand selective for the fibroblast cells which may be found in connective tissues and/or the dermal layer of a human's skin. In another example, the β1 integrin is a ligand selective for the keratinocytes which may be found in the epidermal layer of skin. In some embodiments, the polymeric fibers described herein may include pendant tissue reactive members specific to certain types of cells or tissue, i.e., FGF and β1 integrin.
In other embodiments, the linking member may be a ligand suitable for reacting with biological tissue and which bears a complimentary surface reactive member suitable for interacting with the surface reactive member on the fiber. The ligand may bind naturally to a desired target on the tissue and thus provides a vehicle for transporting and directly binding the polymeric fiber to the tissue. The ligand herein is any molecule or combination of molecules which demonstrates an affinity for biological tissue or a target in the biological tissue. Examples of ligands include nucleic acid probes, antibodies, hapten conjugates, and cell adhesion peptides such as RGD. The mechanisms involved in obtaining and using such ligands are well-known. In embodiments, complimentary surface reactive members or complementary reactive members are incorporated into saccharides or polysaccharides and attached to the fiber prior to contact with cellular tissue, wherein upon contact with the tissue the polysaccharides may be metabolically incorporated into cells. See, e.g., Baskin et al., supra.
Antibodies that specifically recognize antigens are useful in accordance with one embodiment herein. Antibodies which are conjugated to a complimentary surface reactive member are utilized to bind to proteins located on tissue. Monoclonal or polyclonal antibodies are raised against an antigen which can be any component of biological tissue and then purified using conventional techniques. The term “antibody” is intended to include whole antibodies, e.g., of any isotype (IgG, IgA, IgM, IgE, etc.), and to include fragments thereof which are also specifically reactive with a vertebrate, e.g., mammalian, protein. Antibodies may be fragmented using conventional techniques and the fragments screened for utility in the same manner as for whole antibodies. Thus, the term includes segments of proteolytically-cleaved or recombinantly-prepared portions of an antibody molecule that are capable of selectively reacting with a certain protein. Non-limiting examples of such proteolytic and/or recombinant fragments include Fab, F(ab′)2, Fab′, Fv, and single chain antibodies (scFv) containing a V[L] and/or V[H] domain joined by a peptide linker. The scFv's may be covalently or non-covalently linked to form antibodies having two or more binding sites. The present disclosure includes polyclonal, monoclonal or other purified preparations of antibodies and recombinant antibodies.
After purification, the ligands (e.g., antibodies, nucleic acid probes, hapten conjugates and cell adhesion peptides), are conjugated or linked to surface reactive members or complementary reactive members in the manners described above. In addition, surface reactive members or complementary reactive members can be linked to ligands by cross-linking procedures which, in accordance with the present invention, do not cause denaturing or misfolding of the ligands. The terms “linked”, “attached”, or “conjugated” as used herein are used interchangeably and are intended to include any or all of the mechanisms known in the art for coupling the surface reactive members, complementary surface reactive members, or tissue reactive members to the ligand and/or polymer materials. For example, any chemical or enzymatic linkage known to those with skill in the art is contemplated including those which result from photoactivation and the like. Homofunctional and heterobifunctional cross linkers are all suitable. Reactive groups (distinguishable from surface reactive members or complementary surface reactive members or tissue reactive members herein) which can be cross-linked with a cross-linker include primary amines, sulfhydryls, carbonyls, carbohydrates and carboxylic acids.
Cross-linkers are conventionally available with varying lengths of spacer arms or bridges. Cross-linkers suitable for reacting with primary amines include homobifunctional cross-linkers such as imidoesters and N-hydroxysuccinimidyl (NHS) esters. Examples of imidoester cross-linkers include dimethyladipimidate, dimethylpimelimidate, and dimethylsuberimidate. Examples of NHS-ester cross-linkers include disuccinimidyl glutamate, disucciniminidyl suberate and bis(sulfosuccinimidyl) suberate. Accessible amine groups present on the N-termini of peptides react with NHS-esters to form amides. NHS-ester cross-linking reactions can be conducted in phosphate, bicarbonate/carbonate, HEPES and borate buffers. Other buffers can be used if they do not contain primary amines. The reaction of NHS-esters with primary amines should be conducted at a pH of between about 7 and about 9 and a temperature between about 4° C. and 30° C. for about 30 minutes to about 2 hours. The concentration of NHS-ester cross-linker can vary from about 0.1 to about 10 mM. NHS-esters are either hydrophilic or hydrophobic. Hydrophilic NHS-esters are reacted in aqueous solutions although DMSO may be included to achieve greater solubility. Hydrophobic NHS-esters are dissolved in a water miscible organic solvent and then added to the aqueous reaction mixture.
Sulfhydryl reactive cross-linkers include maleimides, alkyl halides, aryl halides and a-haloacyls which react with sulfhydryls to form thiol ether bonds and pyridyl disulfides which react with sulthydryls to produce mixed disulfides. Sulfhydryl groups on peptides and proteins can be generated by techniques known to those with skill in the art, e.g., by reduction of disulfide bonds or addition by reaction with primary amines using 2-iminothiolane. Examples of maleimide cross-linkers include succinimidyl 4-{N-maleimido-methyl) cyclohexane-1-carboxylate and m-maleimidobenzoyl-N-hydroxysuccinimide ester. Examples of haloacetal cross-linkers include N-succinimidyl (4-iodoacetal)aminobenzoate and sulfosuccinimidyl (4-iodoacetal)aminobenzoate. Examples of pyridyl disulfide cross-linkers include 1,4-Di-[3′-2′-pyridyldithio(propionamido)butane] and N-succinimidyl-3-(2-pyridyldithio)-propionate.
Carboxyl groups are cross-linked to primary amines or hydrazides by using carbodimides which result in formation of amide or hydrazone bonds. In this manner, carboxy-termini of peptides or proteins can be linked. Examples of carbodiimide cross-linkers include 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride and N, N1-dicyclohexylcarbodiimide. Arylazide cross-linkers become reactive when exposed to ultraviolet radiation and form aryl nitrene. Examples of arylazide cross-linkers include azidobenzoyl hydrazide and N-5-azido-2 nitrobenzoyloxysuccinimide. Glyoxal cross linkers target the guanidyl portion of arginine. An example of a glyoxal cross-linker is p-azidophenyl glyoxal monohydrate.
Heterobifunctional cross-linkers which possess two or more different reactive groups are suitable for use herein. Examples include cross-linkers which are amine-reactive at one end and sulfhydryl-reactive at the other end such as 4-succinimidyl-oxycarbonyl-a-(2-pyridyldithio)-toluene, N-succinimidyl-3-(2-pyridyldithio)-propionate and the maleimide cross-linkers discussed above.
Attachment of surface reactive members to the polymeric fiber provides the fiber with the ability to form a covalent bond with the linking member upon exposure to the complementary surface reactive members on the linking member.
Attachment of tissue reactive members to the polymeric fiber provides the fiber with the ability to form covalent bonds with the biological tissue upon implantation, thus adhering the fiber to the tissue.
In one embodiment, a linking member is degradable by, e.g., hydrolysis or enzymatic action. In this manner, the fiber can be removable from the tissue and/or the linking member after a period of time. The degradable linkage may be, e.g., chelates or chemically or enzymatically hydrolyzable or absorbable. Illustrative chemically hydrolyzable degradable linkages include polymers, copolymers and oligomers of glycolide, dl-lactide, 1-lactide, caprolactone, dioxanone, and trimethylene carbonate. Illustrative enzymatically hydrolyzable biodegradable linkages include peptidic linkages cleavable by metalloproteinases and collagenases. Additional illustrative degradable linkages include polymers and copolymers of poly(hydroxy acid)s, poly(orthocarbonate)s, poly(anhydride)s, poly(lactone)s, poly(amino acid)s, poly(carbonate)s, poly(saccharide)s and poly(phosphonate)s. In certain embodiments, the degradable linkage may contain ester linkages. Some non-limiting examples include esters of succinic acid, glutaric acid, propionic acid, adipic acid, or amino acids, as well as carboxymethyl esters.
The polymeric fibers described herein may be cut to a desired length or shape, packaged in suture packaging or single or dual packages and sterilized by gamma or beta irradiation at 25-35 Kgy or by ethylene oxide.
Turning now to
As depicted in
Unlike conventional wound closure devices, the polymeric fibers described herein may not need to form a knot or be crimped to maintain closure of the wound tissue. As shown in
Similarly, in
It should be understood that variations can be made to the above embodiments that are with the purview of ordinary skill in the art. For example, other click chemistry reactions are suitable for use herein, e.g., Staudinger reaction of phosphines with alkyl azides. It is contemplated that the above-described cross-linkers may be applied to polymers which make up the fiber to bind reactive members or complementary reactive members thereto. Accordingly, those skilled in the art can envision modifications which are included within the scope of the claimed invention that are not expressly set forth herein.
The present application claims the benefit of and priority to U.S. Provisional Application Ser. No. 61/367,964, filed on Jul. 27, 2010, the entire disclosure of which is incorporated herein by reference.
| Number | Name | Date | Kind |
|---|---|---|---|
| 3767085 | Cannon et al. | Oct 1973 | A |
| 4326532 | Hammar | Apr 1982 | A |
| 4359049 | Redl et al. | Nov 1982 | A |
| 4464321 | Pittalis et al. | Aug 1984 | A |
| 4538920 | Drake | Sep 1985 | A |
| 4753536 | Spehar et al. | Jun 1988 | A |
| 4839345 | Doi et al. | Jun 1989 | A |
| 4857403 | De Lucca et al. | Aug 1989 | A |
| 4880662 | Habrich et al. | Nov 1989 | A |
| 5021207 | De Lucca et al. | Jun 1991 | A |
| 5372585 | Tiefenbrun et al. | Dec 1994 | A |
| 5455308 | Bastiaansen | Oct 1995 | A |
| 5562946 | Fofonoff et al. | Oct 1996 | A |
| 5578662 | Bennett et al. | Nov 1996 | A |
| 5582955 | Keana et al. | Dec 1996 | A |
| 5612050 | Rowe et al. | Mar 1997 | A |
| 5804318 | Pinchuk et al. | Sep 1998 | A |
| 5911942 | Fofonoff et al. | Jun 1999 | A |
| 6107365 | Bertozzi et al. | Aug 2000 | A |
| 6107453 | Zuccato et al. | Aug 2000 | A |
| 6312725 | Wallace et al. | Nov 2001 | B1 |
| 6342591 | Zamora et al. | Jan 2002 | B1 |
| 6451032 | Ory et al. | Sep 2002 | B1 |
| 6534611 | Darling et al. | Mar 2003 | B1 |
| 6552103 | Bertozzi et al. | Apr 2003 | B1 |
| 6570040 | Saxon et al. | May 2003 | B2 |
| 6576000 | Carrison | Jun 2003 | B2 |
| 6624245 | Wallace et al. | Nov 2003 | B2 |
| 6881766 | Hain | Apr 2005 | B2 |
| 7012126 | Matsuda et al. | Mar 2006 | B2 |
| 7105629 | Matsuda et al. | Sep 2006 | B2 |
| 7122703 | Saxon et al. | Oct 2006 | B2 |
| 7144976 | Matsuda et al. | Dec 2006 | B2 |
| 7172877 | Ting | Feb 2007 | B2 |
| 7247692 | Laredo | Jul 2007 | B2 |
| 7294357 | Roby | Nov 2007 | B2 |
| 7371719 | Stupp et al. | May 2008 | B2 |
| 7375234 | Sharpless et al. | May 2008 | B2 |
| 7560588 | Breitenkamp et al. | Jul 2009 | B2 |
| 7618944 | Breitenkamp et al. | Nov 2009 | B2 |
| 7638558 | Breitenkamp et al. | Dec 2009 | B2 |
| 7667012 | Saxon et al. | Feb 2010 | B2 |
| 7795355 | Matyjaszewski et al. | Sep 2010 | B2 |
| 7807619 | Bertozzi et al. | Oct 2010 | B2 |
| 7981444 | Tomalia et al. | Jul 2011 | B2 |
| 7985424 | Tomalia et al. | Jul 2011 | B2 |
| 20020016003 | Saxon et al. | Feb 2002 | A1 |
| 20020161170 | Matsuda et al. | Oct 2002 | A1 |
| 20020169275 | Matsuda et al. | Nov 2002 | A1 |
| 20020173616 | Matsuda et al. | Nov 2002 | A1 |
| 20030100086 | Yao et al. | May 2003 | A1 |
| 20030135238 | Milbocker | Jul 2003 | A1 |
| 20030162903 | Day | Aug 2003 | A1 |
| 20030199084 | Saxon et al. | Oct 2003 | A1 |
| 20030205454 | Hlavinka et al. | Nov 2003 | A1 |
| 20040170752 | Luthra et al. | Sep 2004 | A1 |
| 20040185053 | Govindan | Sep 2004 | A1 |
| 20040209317 | Ting | Oct 2004 | A1 |
| 20050038472 | Furst | Feb 2005 | A1 |
| 20050148032 | Saxon et al. | Jul 2005 | A1 |
| 20050222427 | Sharpless et al. | Oct 2005 | A1 |
| 20050233389 | Ting et al. | Oct 2005 | A1 |
| 20060018948 | Guire et al. | Jan 2006 | A1 |
| 20060036022 | Callaghan et al. | Feb 2006 | A1 |
| 20060085033 | Criscuolo et al. | Apr 2006 | A1 |
| 20060108393 | Heinrich et al. | May 2006 | A1 |
| 20060110782 | Bertozzi et al. | May 2006 | A1 |
| 20060147963 | Barone et al. | Jul 2006 | A1 |
| 20060193865 | Govindan | Aug 2006 | A1 |
| 20060228300 | Chang et al. | Oct 2006 | A1 |
| 20060228357 | Chang et al. | Oct 2006 | A1 |
| 20060240092 | Breitenkamp et al. | Oct 2006 | A1 |
| 20060276658 | Saxon et al. | Dec 2006 | A1 |
| 20070020620 | Finn et al. | Jan 2007 | A1 |
| 20070037964 | Saxon et al. | Feb 2007 | A1 |
| 20070060658 | Diaz et al. | Mar 2007 | A1 |
| 20070077564 | Roitman et al. | Apr 2007 | A1 |
| 20070086942 | Chang et al. | Apr 2007 | A1 |
| 20070087001 | Taylor et al. | Apr 2007 | A1 |
| 20070099251 | Zhang et al. | May 2007 | A1 |
| 20070140966 | Chang et al. | Jun 2007 | A1 |
| 20070178133 | Rolland | Aug 2007 | A1 |
| 20070178448 | Tsao et al. | Aug 2007 | A1 |
| 20070190597 | Agnew et al. | Aug 2007 | A1 |
| 20070244265 | Matyjaszewski et al. | Oct 2007 | A1 |
| 20070244296 | Tomalia et al. | Oct 2007 | A1 |
| 20070249014 | Agnew et al. | Oct 2007 | A1 |
| 20070254006 | Loose et al. | Nov 2007 | A1 |
| 20070258889 | Douglas et al. | Nov 2007 | A1 |
| 20070269369 | Gegg et al. | Nov 2007 | A1 |
| 20070272122 | Lahann et al. | Nov 2007 | A1 |
| 20070275387 | Ju | Nov 2007 | A1 |
| 20070298006 | Tomalia et al. | Dec 2007 | A1 |
| 20080015138 | Hamilton et al. | Jan 2008 | A1 |
| 20080035243 | Breitenkamp et al. | Feb 2008 | A1 |
| 20080038472 | Suzuki et al. | Feb 2008 | A1 |
| 20080045686 | Meagher et al. | Feb 2008 | A1 |
| 20080050731 | Agnew et al. | Feb 2008 | A1 |
| 20080051562 | Chaikof et al. | Feb 2008 | A1 |
| 20080121657 | Voegele et al. | May 2008 | A1 |
| 20080138317 | Fung | Jun 2008 | A1 |
| 20080160017 | Baker et al. | Jul 2008 | A1 |
| 20080166363 | Govindan et al. | Jul 2008 | A1 |
| 20080171067 | Govindan et al. | Jul 2008 | A1 |
| 20080187956 | Carrico et al. | Aug 2008 | A1 |
| 20080199736 | Gadeken et al. | Aug 2008 | A1 |
| 20080200628 | Gadeken et al. | Aug 2008 | A1 |
| 20080207913 | Breitenkamp et al. | Aug 2008 | A1 |
| 20080214436 | Yu et al. | Sep 2008 | A1 |
| 20080214801 | Saxon et al. | Sep 2008 | A1 |
| 20080214831 | Sharpless et al. | Sep 2008 | A1 |
| 20080221043 | Harth et al. | Sep 2008 | A1 |
| 20080241856 | Wong et al. | Oct 2008 | A1 |
| 20080241892 | Roitman et al. | Oct 2008 | A1 |
| 20080242171 | Huang et al. | Oct 2008 | A1 |
| 20080248126 | Cheng et al. | Oct 2008 | A1 |
| 20080267878 | Robillard et al. | Oct 2008 | A1 |
| 20080283572 | Boyden et al. | Nov 2008 | A1 |
| 20080311412 | Fokin et al. | Dec 2008 | A1 |
| 20080317861 | Guan | Dec 2008 | A1 |
| 20090012457 | Childers et al. | Jan 2009 | A1 |
| 20090018646 | Zhao | Jan 2009 | A1 |
| 20090027603 | Samulski et al. | Jan 2009 | A1 |
| 20090053139 | Shi et al. | Feb 2009 | A1 |
| 20090054619 | Baker et al. | Feb 2009 | A1 |
| 20090061010 | Zale et al. | Mar 2009 | A1 |
| 20090069561 | Fokin et al. | Mar 2009 | A1 |
| 20090082224 | Haddleton et al. | Mar 2009 | A1 |
| 20090099108 | Jones | Apr 2009 | A1 |
| 20090124534 | Reineke et al. | May 2009 | A1 |
| 20090137424 | Tsao et al. | May 2009 | A1 |
| 20090155335 | O'Shaughnessey et al. | Jun 2009 | A1 |
| 20090181402 | Finn et al. | Jul 2009 | A1 |
| 20090182151 | Wu et al. | Jul 2009 | A1 |
| 20090202433 | Chang et al. | Aug 2009 | A1 |
| 20090203131 | Reineke et al. | Aug 2009 | A1 |
| 20090214755 | Armani et al. | Aug 2009 | A1 |
| 20090220607 | Kiser et al. | Sep 2009 | A1 |
| 20090240030 | Ju et al. | Sep 2009 | A1 |
| 20090247651 | Kapiamba et al. | Oct 2009 | A1 |
| 20090250588 | Robeson et al. | Oct 2009 | A1 |
| 20090253609 | Fleury et al. | Oct 2009 | A1 |
| 20090259016 | Johnson et al. | Oct 2009 | A1 |
| 20090263468 | McAnulty et al. | Oct 2009 | A1 |
| 20090266467 | Stopek et al. | Oct 2009 | A1 |
| 20090269277 | Chang et al. | Oct 2009 | A1 |
| 20090281250 | DeSimone et al. | Nov 2009 | A1 |
| 20090297609 | Shoichet et al. | Dec 2009 | A1 |
| 20090306310 | Wu et al. | Dec 2009 | A1 |
| 20090312363 | Bradner et al. | Dec 2009 | A1 |
| 20090325292 | Baker et al. | Dec 2009 | A1 |
| 20100011472 | Hugel et al. | Jan 2010 | A1 |
| 20100015046 | Govindan et al. | Jan 2010 | A1 |
| 20100021391 | Douglas et al. | Jan 2010 | A1 |
| 20100034862 | Laronde et al. | Feb 2010 | A1 |
| 20100047258 | Wang et al. | Feb 2010 | A1 |
| 20100048738 | Fleury et al. | Feb 2010 | A1 |
| 20100069578 | Faust et al. | Mar 2010 | A1 |
| 20100098640 | Cohen et al. | Apr 2010 | A1 |
| 20100104589 | Govindan et al. | Apr 2010 | A1 |
| 20100121022 | Musa et al. | May 2010 | A1 |
| 20100159508 | Yang et al. | Jun 2010 | A1 |
| 20100247433 | Tirrell et al. | Sep 2010 | A1 |
| 20100286405 | Fokin et al. | Nov 2010 | A1 |
| 20100291171 | Crescenzi et al. | Nov 2010 | A1 |
| 20100303754 | Turpin et al. | Dec 2010 | A1 |
| 20110008251 | Chang et al. | Jan 2011 | A1 |
| 20110052696 | Hult et al. | Mar 2011 | A1 |
| 20110060107 | Matyjaszewski et al. | Mar 2011 | A1 |
| 20110143435 | Stayton et al. | Jun 2011 | A1 |
| 20110177156 | Szoka, Jr. et al. | Jul 2011 | A1 |
| 20110183417 | Reineke | Jul 2011 | A1 |
| 20110213123 | Bertozzi et al. | Sep 2011 | A1 |
| Number | Date | Country |
|---|---|---|
| 1008260 | Feb 1996 | BE |
| 0490854 | Sep 1996 | EP |
| 1790702 | May 2007 | EP |
| 1795563 | Jun 2007 | EP |
| 1897500 | Aug 2007 | EP |
| 1975230 | Jan 2008 | EP |
| 1 897 500 | Mar 2008 | EP |
| 2014308 | Jan 2009 | EP |
| 2090592 | Aug 2009 | EP |
| WO 0176594 | Oct 2001 | WO |
| WO 2006012569 | Feb 2006 | WO |
| WO 2007003054 | Jan 2007 | WO |
| WO 2007011696 | Jan 2007 | WO |
| WO 2007041394 | Apr 2007 | WO |
| WO 2007121055 | Oct 2007 | WO |
| WO 2008013618 | Jan 2008 | WO |
| WO 2008075955 | Jun 2008 | WO |
| WO 2008077406 | Jul 2008 | WO |
| WO 2008108736 | Sep 2008 | WO |
| WO 2008115694 | Sep 2008 | WO |
| WO 2008120016 | Oct 2008 | WO |
| WO 2010040187 | Apr 2010 | WO |
| WO 2010057080 | May 2010 | WO |
| 2010095052 | Aug 2010 | WO |
| 2010095058 | Aug 2010 | WO |
| WO 2010095044 | Aug 2010 | WO |
| WO 2010095049 | Aug 2010 | WO |
| WO 2010095052 | Aug 2010 | WO |
| WO 2010095058 | Aug 2010 | WO |
| 2012001532 | Jan 2012 | WO |
| WO 2012001532 | Jan 2012 | WO |
| Entry |
|---|
| International Search Report and Written Opinion corresponding to International Application No. PCT/IB2011/002429, date of completion Jul. 20, 2012 and dated Aug. 1, 2012; 14 pages. |
| Shi, et al., “The Immobilization of Proteins on Biodegradable Polymer Fibers via Click Chemistry”, Science Direct, Biomaterials, vol. 29, No. 8, Nov. 26, 2007; pp. 1118-1126. |
| Binder, et al. “Click Chemistry in Polymer Science: An Update”, Macromolecular Rapid Communications, vol. 29, No. 12-13, Jun. 4, 2008; pp. 952-981. |
| Q. Shi, et al., “The Immobilization of Proteins on Biodegradable Polymer Fibers via Click Chemistry”, Biomaterials, 29, (2008), pp. 1118-1126. |
| Jérôme, et al., “Recent Advances in the Synthesis of Aliphatic Polyesters Ring-Opening Polymerization”, Advanced Drug Delivery Reviews, 60, (2008), pp. 1056-1076. |
| Zhang, et al., “2-Azido-2-deoxycellulose: Synthesis and 1, 3-Dipolar Cycloaddition”, Helvetica Chimica Acta, vol. 91, pp. 608-617 (2008). |
| R. Riva, et al., “Contribution of “Click Chemistry” to the Synthesis of Antimicrobial Aliphatic Copolyester”, Polymer 49, (2008), pp. 2023-2028. |
| Baskin, et al., “Copper Free Click Chemistry for Dynamic In Vivo Imaging”, PNAS, vol. 104, No. 43, (Oct. 23, 2007), pp. 16793-16797. |
| Codelli, et al., “Second Generation Difluorinated Cyclooctynes for Copper-Free Click Chemistry”, J. Am. Chem. Soc., vol. 130, No. 34, (2008), pp. 11486-11493. |
| Sletten and Bertozzi, “A Hydrophilic Azacyclooctyne for Cu-free Click Chemistry”, Org. Lett. (2008) 10(14), pp. 3097-3099. |
| Cazalis, et al., “C-Terminal Site-Specific PEGylation of a Truncated Thrombomodulin Mutant with Retention of Full Bioactivity”, Bioconjugate Chem., (2004), 15, pp. 1005-1009. |
| Haridas, et al., “Design and Synthesis of Triazole-based Peptidedendrimers” Tetrahedron Letters, vol. 48, (2007), pp. 4719-4722. |
| Raghavan, et al., “Chemical Probes for Profiling Fatty Acid-associated Proteins in Living Cells”, Bioorg. Med. Chem. Lett., 18 (2008), pp. 5982-5986. |
| LeDévédec, et al., “Separation of Chitosan Oligomers by Immobilized Metal Affinity Chromatography”, Journal of Chromatography A., 2008, 1194(2), pp. 165-171. |
| Hartgerink, et al., “Peptide-amphiphile Nanofibers: A Versatile Scaffold for the Preparation of Self Assembling Materials”, PNAS, 2002; 99(2), pp. 5133-5138. |
| Van Berkel, et al., “Metal-Free Triazole Formation as a Tool for Bioconjugation” Chem Bio Chem, 8, (2007), pp. 1504-1508. |
| Nottelet, et al., Synthesis of an X-ray opaque biodegradable copolyester by chemical modification of poly (ϵ-caprolactone) Biomaterials, 27, (2006), pp. 4943-4954. |
| Smith, et al., “Synthesis and Convenient Functionalization of Azide-labeled Diacyglycerol Analogues for Modular Access to Biologically Active Lipid Probes”, Bioconjugate Chem, 19(9), (2008). pp. 1855-1863. |
| Skierka, et al., “The Influence of Different Acids and Pepsin on the Extractability of Collagen From the Skin of Baltic Cod (Gadus morhua)”, Food Chemisty, 105, (2007), pp. 1302-1306. |
| Eastoe, “The Amino Acid Composition of Mammalian Collagen and Gelatin”, vol. 61, (1955), pp. 589-600. |
| Sicherl, et al., “Orthogonally Protected Sugar Diamino Acids as Building Blocks for Linear and Branched Oligosaccharide Mimetics”, Angew. Chem. Int. Ed. 44, (2005), pp. 2096-2099. |
| Laughlin, et al., “In Vivo Imaging of Membrane-Associated Glycans in Developing Zebrafish”, Science, 320, (2008), pp. 664-667. |
| Worch and Wittmann, “Unexpected Formation of Complex Bridged Tetrazoles via Intramolecular 1,3-dipolar Cycloaddition of 1,2-0-cyanoalkylidene Derivatives of 3-azido-3-deoxy-D-allose”, Carbohydrate Research, 343, (2008), pp. 2118-2129. |
| Witczak et al., “A Click Chemistry Approach to Glycomimetics: Michael addition of 2,3,4,6-tetra-O-acetyl-1-thio-β-D-glucopyranose to 4-deoxy-1,2-O-isopropylident-L-glycero-pent-4-enopyranos-3-ulose-a convenient route to novel 4-deoxy-(1→5)-5-C-thiodisaccharides”, Carbohydrate Research, 342, (2007), 1929-1933 |
| Marra, et al., “Validation of the Copper(1)-Catalyzed Azide-Alkyne Coupling in Ionic Liquids, Synthesis of a Triazole-Linked C-Disaccharide as a Case Study”, J. Org. Chem (2008), 73(6), pp. 2458-2461. |
| Srinivasachari, et al., “Versatile Supramolecular pDNA Vehicles via “Click Polymerization” of β-cyclodextrin with oligoethyleneamines”, Biomaterials, 30, (2009), pp. 928-938. |
| Arora, et al., “A Novel domino-click approach for the synthesis of sugar based unsymmetrical bis-1,2,3-triazoles”, Carbohydrate Research, 343, (2008), 139-144. |
| Chen, et al., “Synthesis of a C3-symmetric (1→6)-N-acetyl-β-D-glucosamine Octadecasaccharide using Click Chemistry”, Carbohydrate Research, 340, (2005), pp. 2476-2482. |
| Gouin, et al., “Multi-Mannosides Based on a Carbohydrate Scaffold: Synthesis, Force Field Development, Molecular Dynamics Studies, and Binding Affinities for Lectin Con A”, J. Org. Chem., 2007, 72(24), pp. 9032-9045. |
| Srinivasachari, Etal., “Effects of Trehalose Click Polymer Length on pDNA Complex Stability and Delivery Efficacy”, Biomaterials, 28, (2007), pp. 2885-2898. |
| Godeau, et al., Lipid-Conjugated Oligonucleotides via “Click Chemistry” Efficiently Inhibit Hepatitis C Virus Translation, J. med. Chem., 2008, 51(15), pp. 2374-4376. |
| Zou et al., “Cu-free Cycloaddition for Identifying Catalytic Active Adenylation Domains of Nonribosomal Peptide Synthesis by phage display”, Bioorganic & Medicinal Chemistry Letters, 18 (2008), pp. 5664-5667. |
| Cantel, et al., “Synthesis and Conformational Analysis of a Cyclic Peptide Obtained via i to i + 4 Intramolecular Side-chain to Side-chain Azide-Alkyne 1,3-Dipolar Cycloaddition” J. Org. Chem., 2008, 73 (15), pp. 5663-5614. |
| Dijk, et al., “Synthesis of Peptide-Based Polymers by Microwave-Assisted Cycloaddition Backbone Polymerization,” Biomacro molecules, 2007, 8(2), pp. 327-330. |
| Köster, et al., “Spectroscopic and Electrochemical Studies of Ferroceryl Triazole Amino Acid and Peptide Bioconjugates Synthesized by Click Chemistry”, Organometallics, 2008, 27(23) pp. 6326-6332. |
| Dijk, et al., “Synthesis and Characterization of Biodegradable Peptide-Baed Polymers Prepared by Microwave-Assisted Click Chemisty”, Biomacromolecules, 2008, 9(10), pp. 2834-2843. |
| Jiang, et al., “Amphiphilic PEG/alkyl-grafted comb polylactides”, J. Polymer Science Part B: Polymer Physics, 45(22), 2007, pp. 5227-5236. |
| Ochs, et al., “Low-Fouling, Biofunctionalized, and Biodegradable Click Capsules”, Biomacromolecules, 2008, 9(12), pp. 3389-3396. |
| Beatty and Tirrell, “Two-color Labeling of Temporally Defined Protein Populations in Mammalian Cells”, Bioorg. Med. Chem. Lett., 18 (2008), pp. 5995-5999. |
| Kolb, et al., “Click Chemistry: Diverse Chemical Function from a Few Good Reactions”, Angewandte Chemie, International Edition, Jun. 2001, pp. 2004-2021. |
| Krouit, et al., “Cellulose surface grafting with polycaprolactone by heterogeneous click-chemistry”, European Polymer Journal 44, Dec. 2008, pp. 4074-4081. |
| Nandivada, et al. “Reactive polymer coatings that ‘Click’.”, Angewandte Chemie, International Edition 45, Apr. 2006, pp. 3360-3363. |
| Ossipov and Hilborn, “Poly(vinyl alcohol)-Based Hydrogels Formed by Click Chemistry”, Macromelecules 2006, 39, pp. 1709-1718. |
| Binder and Sachsenhofer, “Click Chemistry in Polymer and Materials Science”, Macromolecular Rapid Commun. 2007, 28, pp. 15-54. |
| Australian Examination Report, Application No. 2011284449 dated Jan. 7, 2015. |
| Canadian Office Action dated Jul. 10, 2017 in corresponding Canadian Patent Application No. 2,805,987, 3 pages. |
| Number | Date | Country | |
|---|---|---|---|
| 20120027814 A1 | Feb 2012 | US |
| Number | Date | Country | |
|---|---|---|---|
| 61367964 | Jul 2010 | US |
